R & D Center

About R & D Center

Our company’s R&D Center was founded in May 2006 and approved by Zhejiang Technology Department in October 2009 (ZKFT [2009] No. 197), becoming Zhejiang Hi-tech Enterprise R&D Center. It inherits the core value of “Evolving for better Vaccine”, actively carries out research work in new product, new process and new diagnostic reagent of animal vaccines. Up to 2013, our company has carried out 22 R&D projects of all kinds. Among them, we have undertaken 2 Hangzhou major technology innovation projects, 2 Hangzhou foreign knowledge introduction projects, 2 Zhejiang major special projects and 1 state-level industrialized project.

Provincial Hi-tech Technology Enterprise R&D Center Certificate
Provincial Hi-tech Technology Enterprise R&D Center Certificate
  • Science and technology planning project acceptance certificate

    Science and technology planning project acceptance certificate

  • Zhejiang science and technology planning project acceptance certificate

    Zhejiang science and technology planning project acceptance certificate

  • Zhejiang science and technology achievement transformation certificate

    Zhejiang science and technology achievement transformation certificate

  • Hangzhou science and technology development plan contract 1

    Hangzhou science and technology development plan contract 1

    Financial contribution projects at all levels undertaken by us
  • Hangzhou science and technology development plan contract 2

    Hangzhou science and technology development plan contract 2

At the same time, the center makes use of its R&D advantage and actively participates in the construction of R&D platforms of all kinds, becoming biological vaccine and animal testing technique service sub-platform of Hangzhou bio-industry national hi-tech industrial base public service platform. It jointly undertakes Zhejiang key technology innovation team- construction of major animal infectivity prevention technology innovation team with Zhejiang University, which broadens our company’s R&D platform.